Key Details
Annual ROE
-86.57%Beta
-Events Calendar
Next earnings date:
N/ARecent quarterly earnings:
Aug 15, 2022Recent annual earnings:
Mar 23, 2022Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
21 July '22 Chardan Capital
Neutral20 July '22 HC Wainwright & Co.
Neutral28 Apr '22 Chardan Capital
Buy03 June '21 Roth Capital
Buy28 Jan '21 HC Wainwright & Co.
Buy17 Apr '20 Oppenheimer
Outperform27 June '19 Oppenheimer
Outperform15 Oct '18 HC Wainwright & Co.
Buy15 Oct '18 H.C. Wainwright
Buy09 Mar '18 Chardan Capital
NeutralScreeners with VBLT included
No data
Market Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Vascular Biogenics doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Efficiency
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Institutional Ownership
Similar stocks
FAQ
- What is the primary business of Vascular Biogenics?
- What is the ticker symbol for Vascular Biogenics?
- Does Vascular Biogenics pay dividends?
- What sector is Vascular Biogenics in?
- What industry is Vascular Biogenics in?
- What country is Vascular Biogenics based in?
- When did Vascular Biogenics go public?
- Is Vascular Biogenics in the S&P 500?
- Is Vascular Biogenics in the NASDAQ 100?
- Is Vascular Biogenics in the Dow Jones?
- When was Vascular Biogenics's last earnings report?
- When does Vascular Biogenics report earnings?
- Should I buy Vascular Biogenics stock now?
What is the primary business of Vascular Biogenics?
Vascular Biogenics Ltd., a biopharmaceutical company, develops therapeutics for the treatment of cancer and immune-inflammatory diseases in Israel and the United States. It develops VB-601 using monocyte targeting technology for various inflammatory indications. The company was formerly known as Medicard Ltd. and changed its name to Vascular Biogenics Ltd. in January 2003. Vascular Biogenics Ltd. was incorporated in 2000 and is headquartered in Modi'in, Israel.
What is the ticker symbol for Vascular Biogenics?
The ticker symbol for Vascular Biogenics is NASDAQ:VBLT
Does Vascular Biogenics pay dividends?
No, Vascular Biogenics does not pay dividends
What sector is Vascular Biogenics in?
Vascular Biogenics is in the Healthcare sector
What industry is Vascular Biogenics in?
Vascular Biogenics is in the Biotechnology industry
What country is Vascular Biogenics based in?
Vascular Biogenics is headquartered in Israel
When did Vascular Biogenics go public?
Vascular Biogenics's initial public offering (IPO) was on 01 October 2014
Is Vascular Biogenics in the S&P 500?
No, Vascular Biogenics is not included in the S&P 500 index
Is Vascular Biogenics in the NASDAQ 100?
No, Vascular Biogenics is not included in the NASDAQ 100 index
Is Vascular Biogenics in the Dow Jones?
No, Vascular Biogenics is not included in the Dow Jones index
When was Vascular Biogenics's last earnings report?
Vascular Biogenics's most recent earnings report was on 15 August 2022
When does Vascular Biogenics report earnings?
The date for Vascular Biogenics's next earnings report has not been announced yet
Should I buy Vascular Biogenics stock now?
As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions